Global Kinetics Corporation (GKC) is a privately held technology company headquartered in Australia focused on globally commercialising its innovative movement disorder assessment technology, the Parkinson's KinetiGraph™, specifically for the assessment of Parkinson's symptoms.
At UCB their sense of purpose is to help people suffering from severe central nervous system or immunological disorders lead normal, everyday lives. UCB’s ambition is to offer innovative new medicines and ground-breaking solutions that go beyond the drug. They are committed to enabling cutting-edge scientific research that is driven by the patients’ needs.
Medtronic, are committed to innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. More than 30 Australians are diagnosed with Parkinson’s each day. As a leader in medical technology, Medtronic continue their 25 year commitment to restoring health for those living with Parkinson’s and the 100,000 people living with deep brain stimulation therapy.
Since opening in 2002, Fed Square has seen more than 100 million visits and has recently been named the 6th Best Public Square of the World in a list of 10 international icons including Naghsh-e Jahaan Square in Iran and Red Square (Krasnaya ploshchad) in Moscow, Russia.